Clinical Trial Update: Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders [NA]

View source ↗

Summary

A completed clinical study assessing patient outcomes after pharmacogenetic testing in subjects with depression or anxiety disorders, sponsored by AltheaDx.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder

Snippet

Sponsor: AltheaDx | Conditions: Depression, Anxiety | NA | Status: COMPLETED